Everolimus-Eluting Platinum Chromium Coronary Stent System
Real-World Studies Demonstrate Low Event Rates for the SYNERGY Bioabsorbable Polymer (BP) Stent
The SYNERGY BP Stent demonstrated the numerically lowest stent thrombosis rates compared to other DES, despite being used in patients with more complex disease.1 The SCAAR registry is a national, 20-hospital registry of data relating to stent performance in Sweden.
Lowest stent thrombosis rate compared to newer generation DES (n-DES) despite use in patients with statistically more Class B2/C Lesions, Diabetes, Prior PCI, and 3VD.1
We are continuing to pursue clinical evidence of patients in real-world studies through our Investigator Sponsored Research program. Learn more about our Clinical Trial Program